Bridgeway Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,557
Closed -$32.5K 1438
2023
Q3
$32.5K Sell
3,557
-3,333
-48% -$30.5K ﹤0.01% 1328
2023
Q2
$146K Buy
6,890
+3,333
+94% +$70.4K ﹤0.01% 1196
2023
Q1
$95.7K Buy
+3,557
New +$95.7K ﹤0.01% 1248
2022
Q3
Sell
-1,130
Closed -$214K 1463
2022
Q2
$214K Sell
1,130
-2,000
-64% -$379K ﹤0.01% 1080
2022
Q1
$779K Sell
3,130
-1,167
-27% -$290K 0.02% 835
2021
Q4
$669K Hold
4,297
0.01% 902
2021
Q3
$861K Hold
4,297
0.02% 868
2021
Q2
$1.1M Buy
+4,297
New +$1.1M 0.02% 828
2020
Q1
Sell
-3,117
Closed -$1.39M 1374
2019
Q4
$1.39M Hold
3,117
0.02% 654
2019
Q3
$958K Hold
3,117
0.01% 735
2019
Q2
$991K Hold
3,117
0.01% 739
2019
Q1
$1.31M Hold
3,117
0.02% 665
2018
Q4
$950K Hold
3,117
0.01% 751
2018
Q3
$1.12M Hold
3,117
0.01% 836
2018
Q2
$1.14M Hold
3,117
0.01% 828
2018
Q1
$921K Buy
3,117
+784
+34% +$232K 0.01% 882
2017
Q4
$977K Hold
2,333
0.01% 851
2017
Q3
$770K Hold
2,333
0.01% 942
2017
Q2
$553K Buy
2,333
+1,333
+133% +$316K 0.01% 1053
2017
Q1
$344K Sell
1,000
-189
-16% -$65K ﹤0.01% 1179
2016
Q4
$416K Hold
1,189
0.01% 1143
2016
Q3
$478K Buy
1,189
+659
+124% +$265K 0.01% 1119
2016
Q2
$315K Buy
+530
New +$315K ﹤0.01% 1210
2015
Q4
Sell
-58
Closed -$27K 1504
2015
Q3
$27K Sell
58
-416
-88% -$194K ﹤0.01% 1450
2015
Q2
$269K Buy
474
+350
+282% +$199K 0.01% 1281
2015
Q1
$1.06M Hold
124
0.02% 767
2014
Q4
$1.09M Hold
124
0.02% 733
2014
Q3
$585K Buy
+124
New +$585K 0.01% 1001